Ghasem Janbabai
Overview
Explore the profile of Ghasem Janbabai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rostami T, Rad S, Rostami M, Mirhosseini S, Alemi H, Khavandgar N, et al.
Cell Transplant
. 2024 Apr;
33:9636897241246351.
PMID: 38680015
While exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel (Lyfgenia) have been approved by the US Food and Drug Administration (FDA) as the first cell-based gene therapies for the treatment of patients...
2.
Rostami T, Rostami M, Mirhosseini A, Mohammadi S, Nikbakht M, Alemi H, et al.
Stem Cell Res Ther
. 2024 Apr;
15(1):111.
PMID: 38644499
Background: Graft failure (GF) is a rare but serious complication after allogeneic hematopoietic stem cell transplantation (HSCT). Prevention of graft failure remains the most advisable approach as there is no...
3.
Najafi A, Sabaghi M, Asgarian-Omran H, Valadan R, Shekarriz R, Zaboli E, et al.
Asian Pac J Cancer Prev
. 2023 Jun;
24(6):2171-2176.
PMID: 37378949
Objective: BATF, as a transcription factor, and CD112, as a receptor for TIGIT, are involved in T-cell exhaustion. We investigated BATF and CD112 gene expression in the peripheral blood mononuclear...
4.
Tavakoli S, Khalaj F, Kasaeian A, Mousavi S, Mousavian A, Arabi F, et al.
Cell Transplant
. 2023 Apr;
32:9636897231163212.
PMID: 37013251
Imatinib, a selective BCR-ABL tyrosine kinase inhibitor (TKI), was introduced after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for patients with chronic myeloid leukemia (CML). However, the long-term effects of allo-HSCT...
5.
Barkhordar M, Ahmadvand M, Sharifi Aliabadi L, Noorani S, Bagheri Amiri F, Janbabai G, et al.
Vaccines (Basel)
. 2023 Jan;
11(1).
PMID: 36679963
Background: The urgent need for prompt SARS-CoV-2 immunization of hematopoietic stem cell transplant (HSCT) recipients in an endemic area raises many challenges regarding selecting a vaccine platform appropriate for HSCT...
6.
Rostami T, Aghabeigi S, Kiumarsi A, Kasaeian A, Kardoust Parizi M, Mirhosseini A, et al.
J Pediatr Urol
. 2022 Nov;
19(1):54.e1-54.e8.
PMID: 36443142
Background: Hemorrhagic cystitis (HC) is an important adverse event experienced after hematopoietic stem cell transplantation (HSCT). Severe HC could lead to significant morbidity, prolonged hospitalization with increased health-care costs, and...
7.
Ahmadi M, Saeedi M, Hedayatizadeh-Orman A, Eslami M, Janbabai G, Alizadeh-Navaei R
Afr Health Sci
. 2022 Nov;
22(2):323-333.
PMID: 36407347
Background: The use of hair dye for cosmetic purposes appears to be increasing worldwide. As 50-80% of women use hair dye throughout their lifetimes, the possible association between hair dye...
8.
Barkhordar M, Kasaeian A, Janbabai G, Kamranzadeh Fumani H, Tavakoli S, Rashidi A, et al.
Front Immunol
. 2022 Aug;
13:921293.
PMID: 35990618
In haploidentical peripheral blood stem cell transplantation (haplo-PBSCT), the combination of anti-thymocyte globulin and post-transplant cyclophosphamide (ATG/PTCy) has a synergistic impact in preventing graft-versus-host disease (GvHD). However, little is known...
9.
Nabati M, Janbabai G, Najjarpor M, Yazdani J
Caspian J Intern Med
. 2022 Aug;
13(3):511-518.
PMID: 35974948
Background: Cardiovascular disease is the main cause of death among breast cancer survivors. Several chemotherapy drugs may cause cardiovascular toxicity. Our study aimed to assess the late effects of chemotherapy...
10.
Hatefi F, Asgarian-Omran H, Hossein-Nataj H, Akbar A, Shekarriz R, Zaboli E, et al.
Asian Pac J Cancer Prev
. 2022 Jul;
23(7):2225-2231.
PMID: 35901326
Background And Objective: Blockade of immune checkpoint receptors in the treatment of cancers has been mentioned in several studies. Here, we investigated the efficacy of combined blockade of two inhibitory...